MedPath

Analysis of COVID 19 features in HRCT Chest of patients who have no evidence of Tuberculosis infection and comparison between COVID and Tuberculosis imaging features in COVID patients.

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/12/029970
Lead Sponsor
KIMS Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.COVID 19 positive patients with imaging features suggestive of exposure to M. Tuberculosis.

2.Those COVID positive patients who have undergone both HRCT and IGRA.

Exclusion Criteria

COVID 19 negative patients

Absence of any evidence of TB on imaging

Those who have not undergone IGRA

Those who have refused IV contrast study when indicated.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The cases were evaluated by a panel of skilled radiologists for identifying the imaging characteristics to develop a generalised protocol to differentiate COVID-19 from TB in Indian populationTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
To assess the prevalence of TB as co-morbidity with COVID in the study population.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath